0 CHECKOUT

PRODUCT FILTERS

REGION

12,645
9,329
9,256
8,606
8,563

COUNTRY

8,177
1,130
507
473
398

CATEGORIES

  • 2,926
  • 2,596
  • 2,224
  • 2,072
  • 2,071
  • 1,879
    • 353
    • 265
    • 257
    • 254
    • 216
    • 209
    • 181
    • 162
    • 160
    • 148
    • 145
    • 136
    • 100
    • 98
  • 1,480
  • 1,414
  • 1,345
  • 1,291
  • 1,277
  • 1,016
  • 1,005
    • 250
  • 936
  • 592
  • 557
  • 514
  • 407
  • 384
    • 406
      • 57
    • 113
  • 378
  • 163
  • 131
SHOW ALL

PRICE

5,263
10,138
16,806
32,371

PUBLISHED

2,184
7,387
15,598
32,371

PRODUCT TYPE

25,446
2,714
2,560
729
530
223
70
42
29
20
6
1
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Short Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Short Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs,...

Published:  March 2016
Price:  From

Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Stroke-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Stroke-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and...

Published:  March 2016
Price:  From

Ventricular Tachycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Ventricular Tachycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Ventricular Arrhythmia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Ventricular Arrhythmia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Thrombosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Thrombosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  March 2016
Price:  From

Relapsed Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Relapsed Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Peritonitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Peritonitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Pulmonary Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Pulmonary Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Pruritus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients